Protocol · Heal & recover / Skin & anti-aging

Wolverine

Full-body repair plus skin and collagen support.

In this protocol

Overview

Wolverine is Repair with an upgrade - the same BPC-157 and TB-500 foundation, plus GHK-Cu for collagen, skin, and wound-healing support. It's the right choice when tissue healing and skin or collagen support are both goals. BPC-157 is a gastric-derived peptide that accelerates local tissue repair and angiogenesis. It's dosed near the injury site when possible, giving it a concentrated local effect on joints, tendons, and soft tissue. TB-500 is a Thymosin Beta-4 fragment that works systemically - supporting cell migration, new blood vessel formation, and flexibility across the whole body. These two together cover local and systemic repair, which is why they're the classic healing pair. GHK-Cu is a copper-binding peptide that adds a third dimension. It stimulates collagen production, supports wound healing, and is also associated with follicle activity. It can be used as an injectable or topically, and it has both established cosmetic data and supporting evidence for healing. Dosed nightly, it layers on top of the repair stack to rebuild not just deep tissue but the collagen matrix that gives skin, tendons, and connective tissue their structure and resilience. The schedule follows the same logic as Repair - BPC-157 and TB-500 run on the same timing as the core protocol, with GHK-Cu added nightly. Wolverine is for people who are dealing with an injury or healing need while also caring about skin and collagen - or who are coming off a procedure or wound. It's a more complete physical repair protocol than Repair alone. Exact dosing, route choices (injectable vs. topical GHK-Cu), and cycle length are all set with a licensed provider in the PepDepo network at your consult.

How it runs

BPC-157/TB-500 as in Repair, with GHK-Cu nightly.

Adds GHK-Cu's collagen and wound-healing boost on top of the core repair stack.

Questions

How is Wolverine different from the Repair stack?⌄

Wolverine adds GHK-Cu on top of the BPC-157 and TB-500 base. GHK-Cu stimulates collagen production and wound healing, extending the protocol to cover skin, collagen, and connective tissue rebuilding alongside joint and soft-tissue repair.

How is this stack run?⌄

BPC-157 is injected subcutaneously once or twice daily, near the injury site when possible. TB-500 is injected once or twice per week. GHK-Cu is added nightly, either as a subcutaneous injection or topically. The course generally runs 4 to 8 weeks.

Can I use GHK-Cu topically instead of injecting it?⌄

Yes - GHK-Cu is available both as an injectable and as a topical serum. The topical form is very gentle. Your clinician will help you decide which route makes the most sense based on your goals and comfort with injections.

Who is this stack designed for?⌄

Wolverine suits people who are healing an injury, recovering from a procedure, or dealing with wound healing - and who also have skin or collagen goals. If your interest is purely skin or hair, the Glow stack is more focused. If it's purely joint and tissue repair, the Repair stack covers that.

Are there safety concerns with this combination?⌄

BPC-157 and TB-500 both carry a cancer-history exclusion. GHK-Cu has no listed exclusions and is generally well tolerated. Injectable GHK-Cu can cause some sting at the injection site. Your full health history is reviewed at consult.

Will this help with collagen in my skin as well as in tendons?⌄

GHK-Cu is documented for stimulating collagen in skin and is also studied for wound healing and follicle activity. The peptide data supports both skin and connective tissue benefit, though how this shows up for any individual depends on their baseline and the full protocol.

Run this protocol safely

A licensed provider in the PepDepo network sets your exact protocol and dosing.

Book a consult

Education only, not medical advice. Peptides discussed are for informational purposes and many are not FDA-approved. Eligibility, prescribing, compounding, and dispensing are handled by appropriately licensed entities. Exact protocols and dosing are set with a licensed provider in the PepDepo network at consult. Content is pending clinical review.